# Atsena Therapeutics funding rounds and investors

As of 14 Oct 2026, Atsena Therapeutics has raised $150M across 1 verified round on record; latest: $150 million Series C led by Bain Capital, announced 2 Apr 2025.

Atsena Therapeutics develops gene therapies for inherited retinal diseases, targeting conditions like X-linked retinoschisis and Leber congenital amaurosis.

Website: https://atsenatx.com  
Page: https://fireround.dev/companies/atsenatx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-04-02 | Series C | $150 million | Bain Capital | Abingworth, Foundation Fighting Blindness, Hatteras Venture Partners, Lightstone Ventures, Manning Family Foundation, Osage University Partners, Sofinnova Partners, Wellington Management | [fiercebiotech.com](https://www.fiercebiotech.com/biotech/atsena-raises-150m-ocular-gene-therapies-bain-sofinnova-tow) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.